| 1. Ou TM, Lu YJ, Zhang C, Huang ZS, Wang XD, Tan JH, Chen Y, Ma DL, Wong KY, Tang JC, Chan AS, Gu LQ.. (2007) Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives., 50 (7): [PMID:17346034] [10.1021/jm0610088] |
| 2. Zhou JL, Lu YJ, Ou TM, Zhou JM, Huang ZS, Zhu XF, Du CJ, Bu XZ, Ma L, Gu LQ, Li YM, Chan AS.. (2005) Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase., 48 (23): [PMID:16279791] [10.1021/jm050041b] |
| 3. Lu YJ, Ou TM, Tan JH, Hou JQ, Shao WY, Peng D, Sun N, Wang XD, Wu WB, Bu XZ, Huang ZS, Ma DL, Wong KY, Gu LQ.. (2008) 5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation., 51 (20): [PMID:18821749] [10.1021/jm800497p] |
| 4. Tan JH, Ou TM, Hou JQ, Lu YJ, Huang SL, Luo HB, Wu JY, Huang ZS, Wong KY, Gu LQ.. (2009) Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA., 52 (9): [PMID:19354252] [10.1021/jm801600m] |
| 5. Ou TM, Lin J, Lu YJ, Hou JQ, Tan JH, Chen SH, Li Z, Li YP, Li D, Gu LQ, Huang ZS.. (2011) Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex., 54 (16): [PMID:21774525] [10.1021/jm200062u] |
| 6. Li Z, Tan JH, He JH, Long Y, Ou TM, Li D, Gu LQ, Huang ZS.. (2012) Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA., 47 [PMID:22104971] [10.1016/j.ejmech.2011.10.057] |
| 7. He JH, Liu HY, Li Z, Tan JH, Ou TM, Huang SL, An LK, Li D, Gu LQ, Huang ZS.. (2013) New quinazoline derivatives for telomeric G-quadruplex DNA: effects of an added phenyl group on quadruplex binding ability., 63 [PMID:23454529] [10.1016/j.ejmech.2013.01.051] |
| 8. Artese A, Costa G, Distinto S, Moraca F, Ortuso F, Parrotta L, Alcaro S.. (2013) Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data., 68 [PMID:23974014] [10.1016/j.ejmech.2013.07.022] |
| 9. Liu HY, Chen AC, Yin QK, Li Z, Huang SM, Du G, He JH, Zan LP, Wang SK, Xu YH, Tan JH, Ou TM, Li D, Gu LQ, Huang ZS.. (2017) New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription., 60 (13): [PMID:28603988] [10.1021/acs.jmedchem.7b00099] |
| 10. Zhang XR, Wang HW, Tang WL, Zhang Y, Yang H, Hu DX, Ravji A, Marchand C, Kiselev E, Ofori-Atta K, Agama K, Pommier Y, An LK.. (2018) Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents., 61 (22): [PMID:30336023] [10.1021/acs.jmedchem.8b00639] |
| 11. Che T, Chen SB, Tu JL, Wang B, Wang YQ, Zhang Y, Wang J, Wang ZQ, Zhang ZP, Ou TM, Zhao Y, Tan JH, Huang ZS.. (2018) Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response., 61 (8): [PMID:29618208] [10.1021/acs.jmedchem.7b01615] |
| 12. Mendes E, Bahls B, Aljnadi IM, Paulo A.. (2022) Indoloquinolines as scaffolds for the design of potent G-quadruplex ligands., 72 [PMID:35716866] [10.1016/j.bmcl.2022.128862] |
| 13. Nuthakki VK, Mudududdla R, Bharate SB.. (2022) Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids., 227 [PMID:34710743] [10.1016/j.ejmech.2021.113938] |
